DDX3X and lung cancer: Similarly, in lung cancer patient-derived organoids (PDOs), which faithfully reproduce the morphological and genomic features of human lung tumors (Fig. S2), we observed that both the size and viability were markedly decreased in DDX3X deficient lung tumor organoids (Fig. 1G–I).